Mitochondrial permeability transition pore: a promising target for the treatment of Parkinson’s disease
出版年份 2016 全文链接
标题
Mitochondrial permeability transition pore: a promising target for the treatment of Parkinson’s disease
作者
关键词
-
出版物
PROTOPLASMA
Volume 254, Issue 1, Pages 33-42
出版商
Springer Nature
发表日期
2016-01-29
DOI
10.1007/s00709-015-0930-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Mitochondrial Dysfunction in Parkinson's Disease
- (2015) Hyo Eun Moon et al. Experimental Neurobiology
- Determinants of functional disability in Huntington's disease: Role of cognitive and motor dysfunction
- (2014) Christopher A. Ross et al. MOVEMENT DISORDERS
- The benefits of pramipexole selection in the treatment of Parkinson’s disease
- (2014) Mine Silindir et al. NEUROLOGICAL SCIENCES
- Safinamide for the treatment of Parkinson’s disease
- (2014) Rukmini Mridula Kandadai et al. Expert Review of Clinical Pharmacology
- Minocycline, levodopa and MnTMPyP induced changes in the mitochondrial proteome profile of MPTP and maneb and paraquat mice models of Parkinson's disease
- (2013) Anubhuti Dixit et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Current status of safinamide for the drug portfolio of Parkinson’s disease therapy
- (2013) Thomas Müller Expert Review of Neurotherapeutics
- Interaction of the antibiotic minocycline with liver mitochondria - role of membrane permeabilization in the impairment of respiration
- (2013) Peter Schönfeld et al. FEBS Journal
- Oxidative damage to macromolecules in human Parkinson disease and the rotenone model
- (2013) Laurie H. Sanders et al. FREE RADICAL BIOLOGY AND MEDICINE
- Parkinson disease: from pathology to molecular disease mechanisms
- (2013) David T. Dexter et al. FREE RADICAL BIOLOGY AND MEDICINE
- Pesticides, Microglial NOX2, and Parkinson's Disease
- (2013) Thomas Taetzsch et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- Exposure to pesticides or solvents and risk of Parkinson disease
- (2013) G. Pezzoli et al. NEUROLOGY
- Autophagy and apoptosis dysfunction in neurodegenerative disorders
- (2013) Saeid Ghavami et al. PROGRESS IN NEUROBIOLOGY
- Paths from Pesticides to Parkinson's
- (2013) F. Kamel SCIENCE
- The mitochondrial permeability transition pore: a mystery solved?
- (2013) Paolo Bernardi Frontiers in Physiology
- Role of Oxidative Stress in Parkinson's Disease
- (2013) Onyou Hwang Experimental Neurobiology
- The mitochondrial permeability transition pore (PTP) — An example of multiple molecular exaptation?
- (2012) Angelo Vianello et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Physiological Roles of the Permeability Transition Pore
- (2012) Catherine Brenner et al. CIRCULATION RESEARCH
- Gene–environment interactions in Parkinson's disease: Specific evidence in humans and mammalian models
- (2012) Jason R. Cannon et al. NEUROBIOLOGY OF DISEASE
- Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism
- (2012) David N. Hauser et al. NEUROBIOLOGY OF DISEASE
- Mitochondrial Quality Control and Dynamics in Parkinson's Disease
- (2011) Melissa K. McCoy et al. ANTIOXIDANTS & REDOX SIGNALING
- Mitochondrial Dynamics and Parkinson's Disease: Focus on Parkin
- (2011) Kah-Leong Lim et al. ANTIOXIDANTS & REDOX SIGNALING
- Mitochondrial permeability transition in Ca2+-dependent apoptosis and necrosis
- (2011) Andrea Rasola et al. CELL CALCIUM
- Mitochondria as a Therapeutic Target for Aging and Neurodegenerative Diseases
- (2011) P. H. Reddy et al. Current Alzheimer Research
- Mitochondrial dynamics and mitophagy in Parkinson's disease: disordered cellular power plant becomes a big deal in a major movement disorder
- (2011) Yuzuru Imai et al. CURRENT OPINION IN NEUROBIOLOGY
- Etiology and pathogenesis of Parkinson's disease
- (2011) Anthony H. Schapira et al. MOVEMENT DISORDERS
- The dopamine-D2-receptor agonist ropinirole dose-dependently blocks the Ca2+-triggered permeability transition of mitochondria
- (2010) Suhel Parvez et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update
- (2010) Karen Nuytemans et al. HUMAN MUTATION
- Mitochondrial Quality Control and Parkinson’s Disease: A Pathway Unfolds
- (2010) Inês Pimenta de Castro et al. MOLECULAR NEUROBIOLOGY
- Missing pieces in the Parkinson's disease puzzle
- (2010) Jose A Obeso et al. NATURE MEDICINE
- Rasagiline: A novel anti-Parkinsonian monoamine oxidase-B inhibitor with neuroprotective activity
- (2010) Orly Weinreb et al. PROGRESS IN NEUROBIOLOGY
- Mitochondria, calcium and cell death: A deadly triad in neurodegeneration
- (2009) Fulvio Celsi et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Mitochondrial dysfunction in Parkinson's disease
- (2009) Konstanze F. Winklhofer et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- NMR studies of an immunomodulatory benzodiazepine binding to its molecular target on the mitochondrial F1F0-ATPase
- (2009) Andrew C. Stelzer et al. BIOPOLYMERS
- Interaction of mitochondrial potassium channels with the permeability transition pore
- (2009) Yu Cheng et al. FEBS LETTERS
- Crosstalk signaling between mitochondrial Ca2+ and ROS
- (2009) Robert et al. Frontiers in Bioscience-Landmark
- Recent progress in elucidating the molecular mechanism of the mitochondrial permeability transition pore
- (2008) Anna W.C. Leung et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis
- (2008) Rebecca Banerjee et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- The enigma of caspase-2: the laymen's view
- (2008) G Krumschnabel et al. CELL DEATH AND DIFFERENTIATION
- Mitochondrial alterations in Parkinson’s disease: new clues
- (2008) Miquel Vila et al. JOURNAL OF NEUROCHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started